Global Rabies Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
According to APO Research, The global Rabies Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.
The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Rabies Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.
The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK (Novartis)
- Sanofi-Pasteur
- Chengda
- Yisheng
- Prcmise
- VACN
- Changsheng
- BCHT
- Hissen
- Vero Cell Rabies Vaccine
- BHK
- Chick Embryo Cell Rabies Vaccine
- Others
- Pre-exposure Prophylaxis
- Post-exposure Prophylaxis
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Rabies Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Rabies Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Rabies Vaccine Market by Type
1.3.1 Vero Cell Rabies Vaccine
1.3.2 BHK
1.3.3 Chick Embryo Cell Rabies Vaccine
1.3.4 Others
1.4 Global Rabies Vaccine Market Size by Type
1.4.1 Global Rabies Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Rabies Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Rabies Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Rabies Vaccine Industry Trends
2.2 Rabies Vaccine Industry Drivers
2.3 Rabies Vaccine Industry Opportunities and Challenges
2.4 Rabies Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Rabies Vaccine Revenue (2019-2024)
3.2 Global Top Players by Rabies Vaccine Sales (2019-2024)
3.3 Global Top Players by Rabies Vaccine Price (2019-2024)
3.4 Global Rabies Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Rabies Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Rabies Vaccine Company, Product Type & Application
3.7 Global Rabies Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Rabies Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Rabies Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Rabies Vaccine Tier 1, Tier 2, and Tier
4 RABIES VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Rabies Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Rabies Vaccine Historic Market Size by Region
4.2.1 Global Rabies Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Rabies Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Rabies Vaccine Forecasted Market Size by Region
4.3.1 Global Rabies Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Rabies Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 RABIES VACCINE BY APPLICATION
5.1 Rabies Vaccine Market by Application
5.1.1 Pre-exposure Prophylaxis
5.1.2 Post-exposure Prophylaxis
5.2 Global Rabies Vaccine Market Size by Application
5.2.1 Global Rabies Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Rabies Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Rabies Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 GSK (Novartis)
6.1.1 GSK (Novartis) Comapny Information
6.1.2 GSK (Novartis) Business Overview
6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
6.1.5 GSK (Novartis) Recent Developments
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Comapny Information
6.2.2 Sanofi-Pasteur Business Overview
6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments
6.3 Chengda
6.3.1 Chengda Comapny Information
6.3.2 Chengda Business Overview
6.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengda Rabies Vaccine Product Portfolio
6.3.5 Chengda Recent Developments
6.4 Yisheng
6.4.1 Yisheng Comapny Information
6.4.2 Yisheng Business Overview
6.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yisheng Rabies Vaccine Product Portfolio
6.4.5 Yisheng Recent Developments
6.5 Prcmise
6.5.1 Prcmise Comapny Information
6.5.2 Prcmise Business Overview
6.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Prcmise Rabies Vaccine Product Portfolio
6.5.5 Prcmise Recent Developments
6.6 VACN
6.6.1 VACN Comapny Information
6.6.2 VACN Business Overview
6.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 VACN Rabies Vaccine Product Portfolio
6.6.5 VACN Recent Developments
6.7 Changsheng
6.7.1 Changsheng Comapny Information
6.7.2 Changsheng Business Overview
6.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Changsheng Rabies Vaccine Product Portfolio
6.7.5 Changsheng Recent Developments
6.8 BCHT
6.8.1 BCHT Comapny Information
6.8.2 BCHT Business Overview
6.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BCHT Rabies Vaccine Product Portfolio
6.8.5 BCHT Recent Developments
6.9 Hissen
6.9.1 Hissen Comapny Information
6.9.2 Hissen Business Overview
6.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hissen Rabies Vaccine Product Portfolio
6.9.5 Hissen Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Rabies Vaccine Sales by Country
7.1.1 North America Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Rabies Vaccine Sales by Country (2019-2024)
7.1.3 North America Rabies Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Rabies Vaccine Market Size by Country
7.2.1 North America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Rabies Vaccine Market Size by Country (2019-2024)
7.2.3 North America Rabies Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Rabies Vaccine Sales by Country
8.1.1 Europe Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Rabies Vaccine Sales by Country (2019-2024)
8.1.3 Europe Rabies Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Rabies Vaccine Market Size by Country
8.2.1 Europe Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Rabies Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Rabies Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Rabies Vaccine Sales by Country
9.1.1 Asia-Pacific Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Rabies Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Rabies Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Rabies Vaccine Market Size by Country
9.2.1 Asia-Pacific Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Rabies Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Rabies Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Rabies Vaccine Sales by Country
10.1.1 Latin America Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Rabies Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Rabies Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Rabies Vaccine Market Size by Country
10.2.1 Latin America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Rabies Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Rabies Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Rabies Vaccine Sales by Country
11.1.1 Middle East and Africa Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Rabies Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Rabies Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Rabies Vaccine Market Size by Country
11.2.1 Middle East and Africa Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Rabies Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Rabies Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Rabies Vaccine Value Chain Analysis
12.1.1 Rabies Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Rabies Vaccine Production Mode & Process
12.2 Rabies Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Rabies Vaccine Distributors
12.2.3 Rabies Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Rabies Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Rabies Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Rabies Vaccine Market by Type
1.3.1 Vero Cell Rabies Vaccine
1.3.2 BHK
1.3.3 Chick Embryo Cell Rabies Vaccine
1.3.4 Others
1.4 Global Rabies Vaccine Market Size by Type
1.4.1 Global Rabies Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Rabies Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Rabies Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Rabies Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Rabies Vaccine Industry Trends
2.2 Rabies Vaccine Industry Drivers
2.3 Rabies Vaccine Industry Opportunities and Challenges
2.4 Rabies Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Rabies Vaccine Revenue (2019-2024)
3.2 Global Top Players by Rabies Vaccine Sales (2019-2024)
3.3 Global Top Players by Rabies Vaccine Price (2019-2024)
3.4 Global Rabies Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Rabies Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Rabies Vaccine Company, Product Type & Application
3.7 Global Rabies Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Rabies Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Rabies Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Rabies Vaccine Tier 1, Tier 2, and Tier
4 RABIES VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Rabies Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Rabies Vaccine Historic Market Size by Region
4.2.1 Global Rabies Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Rabies Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Rabies Vaccine Forecasted Market Size by Region
4.3.1 Global Rabies Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Rabies Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 RABIES VACCINE BY APPLICATION
5.1 Rabies Vaccine Market by Application
5.1.1 Pre-exposure Prophylaxis
5.1.2 Post-exposure Prophylaxis
5.2 Global Rabies Vaccine Market Size by Application
5.2.1 Global Rabies Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Rabies Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Rabies Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Rabies Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 GSK (Novartis)
6.1.1 GSK (Novartis) Comapny Information
6.1.2 GSK (Novartis) Business Overview
6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
6.1.5 GSK (Novartis) Recent Developments
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Comapny Information
6.2.2 Sanofi-Pasteur Business Overview
6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments
6.3 Chengda
6.3.1 Chengda Comapny Information
6.3.2 Chengda Business Overview
6.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengda Rabies Vaccine Product Portfolio
6.3.5 Chengda Recent Developments
6.4 Yisheng
6.4.1 Yisheng Comapny Information
6.4.2 Yisheng Business Overview
6.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yisheng Rabies Vaccine Product Portfolio
6.4.5 Yisheng Recent Developments
6.5 Prcmise
6.5.1 Prcmise Comapny Information
6.5.2 Prcmise Business Overview
6.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Prcmise Rabies Vaccine Product Portfolio
6.5.5 Prcmise Recent Developments
6.6 VACN
6.6.1 VACN Comapny Information
6.6.2 VACN Business Overview
6.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 VACN Rabies Vaccine Product Portfolio
6.6.5 VACN Recent Developments
6.7 Changsheng
6.7.1 Changsheng Comapny Information
6.7.2 Changsheng Business Overview
6.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Changsheng Rabies Vaccine Product Portfolio
6.7.5 Changsheng Recent Developments
6.8 BCHT
6.8.1 BCHT Comapny Information
6.8.2 BCHT Business Overview
6.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BCHT Rabies Vaccine Product Portfolio
6.8.5 BCHT Recent Developments
6.9 Hissen
6.9.1 Hissen Comapny Information
6.9.2 Hissen Business Overview
6.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hissen Rabies Vaccine Product Portfolio
6.9.5 Hissen Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Rabies Vaccine Sales by Country
7.1.1 North America Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Rabies Vaccine Sales by Country (2019-2024)
7.1.3 North America Rabies Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Rabies Vaccine Market Size by Country
7.2.1 North America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Rabies Vaccine Market Size by Country (2019-2024)
7.2.3 North America Rabies Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Rabies Vaccine Sales by Country
8.1.1 Europe Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Rabies Vaccine Sales by Country (2019-2024)
8.1.3 Europe Rabies Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Rabies Vaccine Market Size by Country
8.2.1 Europe Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Rabies Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Rabies Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Rabies Vaccine Sales by Country
9.1.1 Asia-Pacific Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Rabies Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Rabies Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Rabies Vaccine Market Size by Country
9.2.1 Asia-Pacific Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Rabies Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Rabies Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Rabies Vaccine Sales by Country
10.1.1 Latin America Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Rabies Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Rabies Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Rabies Vaccine Market Size by Country
10.2.1 Latin America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Rabies Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Rabies Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Rabies Vaccine Sales by Country
11.1.1 Middle East and Africa Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Rabies Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Rabies Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Rabies Vaccine Market Size by Country
11.2.1 Middle East and Africa Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Rabies Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Rabies Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Rabies Vaccine Value Chain Analysis
12.1.1 Rabies Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Rabies Vaccine Production Mode & Process
12.2 Rabies Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Rabies Vaccine Distributors
12.2.3 Rabies Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
